Calif. Fertility Clinic Hit With FDA Warning

Law360, New York (November 5, 2008, 12:00 AM EST) -- A Southern California fertility center neglected to screen donors or properly test sperm for diseases including chlamydia and gonorrhea, the U.S. Food and Drug Administration said in a letter released Tuesday.

The FDA's Oct. 9 letter to the Tarzana, Calif.-based Center for Fertility and Gynecology unveils a slew of violations to federal regulations under the Public Health Service Act. The violations were discovered during a mid-June inspection.

The FDA charges relate to both anonymous and “directed” donors whose sperm fertilized eggs in vitro, or outside of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.